Skip to main content
Signal8
Kapoor Vishal profile photo

Vishal Kapoor

CIK: 0001798946

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 3, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    7.5K shares-

1-1 of 1

About Kapoor Vishal

Kapoor Vishal (SEC CIK 0001798946) files insider reports with the SEC as Director of Jasper Therapeutics, Inc. (JSPR).

Signal8 holds 1 ownership filing by Kapoor Vishal, a Form 4, filed on Jul 3, 2025. Those filings report 1 transaction, the latest on Jul 3, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Kapoor Vishal's filings is in REDWOOD CITY, CA.

Recent filings by Kapoor Vishal

  • Jul 3, 2025: Grant or award of JSPR derivative securities (Form 4, code A).

Other insiders filing for Jasper Therapeutics, Inc. (JSPR)

How to read Form 4 transaction codes